Progression of leptomeningeal metastases in advanced EGFR-mutated non-small cell lung cancer

被引:0
|
作者
Zhao, Q. [1 ]
Deng, L. [2 ,3 ]
Zhang, Y. [2 ,3 ]
Zhou, X. [2 ,3 ]
Li, Y. [2 ,3 ]
Yu, M. [2 ,3 ]
Zhou, L. [2 ,3 ]
Zou, B. [2 ,3 ]
Liu, Y. [2 ,3 ]
Lu, Y. [2 ,3 ]
机构
[1] Sichuan Univ, West China Sch Med, West China Hosp, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Thorac Oncol, Ctr Canc, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1093/annonc/mdw383.42
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1242P
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Leptomeningeal carcinomatosis from EGFR-mutated non-small cell lung cancer
    Iuchi, T.
    Shingyoji, M.
    Setoguchi, T.
    Yoshida, Y.
    Ashinuma, H.
    Hasegawa, Y.
    Sakaida, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease
    Alzate, Juan Diego
    Mullen, Reed
    Mashiach, Elad
    Bernstein, Kenneth
    Vasconcellos, Fernando De Nigris
    Rotmann, Lauren
    Berger, Assaf
    Qu, Tanxia
    Silverman, Joshua S.
    Golfinos, John G.
    Donahue, Bernadine R.
    Kondziolka, Douglas
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (02) : 387 - 396
  • [3] EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease
    Juan Diego Alzate
    Reed Mullen
    Elad Mashiach
    Kenneth Bernstein
    Fernando De Nigris Vasconcellos
    Lauren Rotmann
    Assaf Berger
    Tanxia Qu
    Joshua S. Silverman
    John G. Golfinos
    Bernadine R. Donahue
    Douglas Kondziolka
    Journal of Neuro-Oncology, 2023, 164 (2) : 387 - 396
  • [4] Advancing leptomeningeal metastases treatment in EGFR-mutated non-small cell lung cancer: lessons from the BLOSSOM trial
    Bortolot, Martina
    Huijs, Jarno W. J.
    Brandsma, Dieta
    Compter, Annette
    van Geel, Robin M. J. M.
    Hendriks, Lizza E. L.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2025, 14 (01) : 7 - 13
  • [5] Treatment Response To Osimertinib In EGFR-Mutated Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Series
    Li, Huiying
    Yu, Tingting
    Huang, Mingmin
    Guo, Aibin
    Qian, Xiaoping
    Yin, Zhenyu
    ONCOTARGETS AND THERAPY, 2019, 12 : 7785 - 7790
  • [6] Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer
    Bhandari, Shruti
    Dunlap, Neal
    Kloecker, Goetz
    JOURNAL OF THORACIC DISEASE, 2021, 13 (05) : 3230 - 3234
  • [7] Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors
    Saboundji, Karima
    Auliac, Jean-Bernard
    Perol, Maurice
    Francois, Geraldine
    Janicot, Henri
    Marcq, Marie
    Dubos-Arvis, Catherine
    Renault, Aldo
    Guisier, Florian
    Odier, Luc
    Gervais, Radj
    Chouaid, Christos
    TARGETED ONCOLOGY, 2018, 13 (04) : 501 - 507
  • [8] Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors
    Karima Saboundji
    Jean-Bernard Auliac
    Maurice Pérol
    Géraldine François
    Henri Janicot
    Marie Marcq
    Catherine Dubos-Arvis
    Aldo Renault
    Florian Guisier
    Luc Odier
    Radj Gervais
    Christos Chouaïd
    Targeted Oncology, 2018, 13 : 501 - 507
  • [9] Afatinib After Progression on Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer
    Aredo, Jacqueline, V
    Wakelee, Heather A.
    Neal, Joel W.
    Padda, Sukhmani K.
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 30
  • [10] Leptomeningeal metastases in EGFR-mutated non-small cell lung carcinoma: Management after tyrosine kinase inhibitors
    Flippot, R.
    Auclin, E.
    Biondani, P.
    Le Rhun, E.
    Planchard, D.
    Caramella, C.
    Le Pechoux, C.
    Lacroix, L.
    Mezquita, L.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S85 - S86